Guidance for market authorization requirements for COVID-19 drugs: Overview

Name: Guidance for market authorization requirements for COVID-19 drugs: Overview
Creator: Health Canada
License: https://open.canada.ca/en/open-government-licence-canada

This document provides guidance to drug manufacturers seeking authorization for their drug manufactured, sold, or represented for use in relation to COVID-19. The guidance explains recent changes to the regulatory process for new COVID-19 drugs.

Publisher: Health Canada
Resources: 2
Catalogue metadata updated: 2022-07-28

Data overview

Formats: HTML
File languages: English, French

Official sources and licences

Government of Canada Open Data
Open Government Licence – Canada

Resources

Guidance for market authorization requirements for COVID-19 drugs: Overview (French, HTML) HTML
Guidance for market authorization requirements for COVID-19 drugs: Overview (English, HTML) HTML

Related open data

Health Canada